【Company Research】Haidilao (6862 HK) – Reforms on track, but hindered by pandemic |
【Company Research】Shengyi Technology (600183 CH) – Weaker 4Q21 with limited pricing upside in 2022; D/G to HOLD |
【Company Research】I-Mab BioPharma (IMAB US) – A significantly undervalued biotech company with solid pipeline assets |
【Fixed Income Research】TBLAIJ – Loan conclusion should lead to positive rating action |
【Company Research】Suspension of Coverage |
【Company Research】Yili Industrial (600887 CH) – Promotional expense on Winter Olympics could weigh on 4Q results |
【Sector Research】China Software & IT Services – China cloud market to recover in 2022E |
【Company Research】Termination of Coverage |
【行业研究】中国汽车行业 – 分析师路演反馈:爱之深,忧之切? |
【Sector Research】China Consumer Staples – Cherry-picking winners amid a de-risking mentality; our top picks: CRB/ Mengniu/ Feihe |